Aromatase inhibitors for infertility in polycystic ovary syndrome. The beginning or the end of a new era?
A meta-analysis of four trials showed significant advantage in pregnancy and delivery rates with aromatase inhibitors compared with CC in women with PCOS. A recent randomized trial demonstrated no clear benefit.
To access this article, please choose from the options below
Presented at the 5th World Congress on Ovulation Induction, Rome, Italy, September 13–15, 2007.
PII: S0015-0282(07)03869-1
doi:10.1016/j.fertnstert.2007.10.016
© 2008 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

